Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Won Yi

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
JACC. Heart Failure|March 5, 2025
Leveraging Cohort Creation in Datasets: An Important Next Step for Facilitating the Implementation of Guideline-Directed Medical TherapiesTae Won Yi, Adeera Levin
Seminars in Nephrology|June 19, 2022
Sex, Gender, and Cardiovascular Disease in Chronic Kidney DiseaseTae Won Yi, Adeera Levin
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Evidence-Based Decision Making 4: Clinical Practice GuidelinesTae Won Yi, Sine Donnellan, Adeera Levin
Journal of Internal Medicine|May 21, 2026
Authors reply: "Global kidney health: Are we failing the silent pandemic?"Tae Won Yi, Daniel V O'Hara, Adeera Levin
Canadian Journal of Kidney Health and Disease|September 21, 2020
A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney DiseaseTae Won Yi, Adeera Levin, Micheli Bevilacqua, et al.
Nature Reviews. Nephrology|January 12, 2026
Next-generation therapeutics for diabetic kidney diseaseTae Won Yi, Vikas S Sridhar, Jennifer Scott, et al.
Canadian Journal of Kidney Health and Disease|July 2, 2026
Barriers and Facilitators for Sodium-Glucose Cotransporter-2 Inhibitor Uptake and Implementation in Australia - Perspectives From Clinicians and Patients: An Interview StudyDaniel V O'Hara, Tae Won Yi, Meg J Jardine, et al.
Nephrology (Carlton, Vic.)|September 30, 2022
Digital health technologies to support medication adherence in chronic kidney diseaseDaniel V O'Hara, Tae Won Yi, Vincent W Lee, et al.
Canadian Journal of Kidney Health and Disease|December 29, 2022
Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort StudyTae Won Yi, Mohammad Atiquzzaman, Yuyan Zheng, et al.
Canadian Journal of Kidney Health and Disease|January 1, 2024
Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation ResearchTae Won Yi, Daniel V O'Hara, Brendan Smyth, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
JACC. Heart Failure|March 5, 2025
Leveraging Cohort Creation in Datasets: An Important Next Step for Facilitating the Implementation of Guideline-Directed Medical TherapiesTae Won Yi, Adeera Levin
Seminars in Nephrology|June 19, 2022
Sex, Gender, and Cardiovascular Disease in Chronic Kidney DiseaseTae Won Yi, Adeera Levin
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Evidence-Based Decision Making 4: Clinical Practice GuidelinesTae Won Yi, Sine Donnellan, Adeera Levin
Journal of Internal Medicine|May 21, 2026
Authors reply: "Global kidney health: Are we failing the silent pandemic?"Tae Won Yi, Daniel V O'Hara, Adeera Levin
Canadian Journal of Kidney Health and Disease|September 21, 2020
A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney DiseaseTae Won Yi, Adeera Levin, Micheli Bevilacqua, et al.
Nature Reviews. Nephrology|January 12, 2026
Next-generation therapeutics for diabetic kidney diseaseTae Won Yi, Vikas S Sridhar, Jennifer Scott, et al.
Canadian Journal of Kidney Health and Disease|July 2, 2026
Barriers and Facilitators for Sodium-Glucose Cotransporter-2 Inhibitor Uptake and Implementation in Australia - Perspectives From Clinicians and Patients: An Interview StudyDaniel V O'Hara, Tae Won Yi, Meg J Jardine, et al.
Nephrology (Carlton, Vic.)|September 30, 2022
Digital health technologies to support medication adherence in chronic kidney diseaseDaniel V O'Hara, Tae Won Yi, Vincent W Lee, et al.
Canadian Journal of Kidney Health and Disease|December 29, 2022
Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort StudyTae Won Yi, Mohammad Atiquzzaman, Yuyan Zheng, et al.
Canadian Journal of Kidney Health and Disease|January 1, 2024
Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation ResearchTae Won Yi, Daniel V O'Hara, Brendan Smyth, et al.
Pageof 3